Last updated 19 days ago

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

1130 patients around the world

Available in Spain, Argentina

Hoffmann-La Roche

9Research sites

1130Patients around the world

This study is for people with

Non-Hodgkin Lymphoma

Large B-cell lymphoma

Lymphoma

Non-Hodgkin lymphoma

Requirements for the patient

To 80 Years

All Gender

Medical requirements

Sites

Centro de Internación e Investigación Clínica FUNDALEU

Recruiting

J. E. Uriburu 1450, CABA, Buenos Aireshttps://www.fundaleu.org/

Sanatorio Allende (Nueva Córdoba)

Recruiting

Hipolito Yrigoyen 384, Córdoba

Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires

Recruiting

Av. Crámer 1180, CABA, Buenos Aires

Centro Médico Austral OMI - CABA

Montevideo 955, C1019ABS Cdad. Autónoma de Buenos Aires, Argentina

Hospital Alemán

Recruiting

Av. Pueyrredón 1640, CABA, Buenos Aires

Instituto D'Or de Pesquisa e Ensino - Sao Paulo

Recruiting

Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000

Hospital General de Mexico Dr. Eduardo Liceaga - Ciudad de México

Recruiting

Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, Ciudad de México

Instituto Nacional de Cancerología - Ciudad de México

Recruiting

Avenida San Fernando 22, México DF

Health Pharma Professional Research

Recruiting

Dakota 351, Nápoles, Benito Juárez, 03840 Ciudad de México, CDMX, Mexico

StudyGO44145

SponsorHoffmann-La Roche

Conditions

Large B-cell lymphomaNon-Hodgkin lymphoma

Requirements

To 80 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT06047080